Purchase Order HHSN272201700771P

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the University of Oxford valued at $16,000.00 on June 22, 2017, for participation in the NIH Oxford-Cambridge Scholars Program. Place of performance is Great Britain, United Kingdom. The order funds tuition and fees supporting fellows in the doctoral training program, with ultimate completion by July 31, 2018. This is a firm fixed price purchase order with no set-aside applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to University of Oxford valued at $16,000 on June 4, 2018, to support a new member of the NIH Oxford-Cambridge Scholars Program, with ultimate completion on June 10, 2019. Performance takes place in Great Britain, United Kingdom. The order covers tuition and related costs for graduate training under the doctoral scholars initiative.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the University of Oxford on June 23, 2017, valued at $16,000.00, with an ultimate completion date of July 31, 2018. The order, issued under firm fixed price terms, supports tuition and fees for fellows participating in the NIH Oxford-Cambridge Scholars Program. Performance takes place in Great Britain, United Kingdom.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to University of Oxford valued at $16,000 on June 26, 2017, to support a new member of the NIH Oxford-Cambridge Scholars Program. Performance occurs in Great Britain, United Kingdom, with an ultimate completion date of June 30, 2018. The order funds tuition and fees for doctoral training under this NIH graduate fellowship initiative.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to University of Oxford on May 24, 2018, for $16,000.00, with final completion on May 31, 2019. The order funds tuition and fees for a new member of the NIH Oxford-Cambridge Scholars Program. Performance takes place in Great Britain, United Kingdom.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to University of Oxford for $16,000 on June 22, 2017, to support a new member of the NIH Oxford-Cambridge Scholars Program through July 31, 2018. Work is performed in Great Britain, United Kingdom. The order funds tuition and fees for doctoral training under the joint NIH fellows initiative.</p>

<p>The National Institute of Allergy and Infectious Diseases issued a purchase order to the University of Oxford on June 26, 2017, valued at $16,000.00, to support a new member of the NIH Oxford-Cambridge Scholars Program through July 31, 2018. Work is performed in Great Britain, United Kingdom. The order funds tuition and fees for doctoral training under the joint Oxford-Cambridge fellowship initiative.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the University of Cambridge for $16,000.00 on July 12, 2017. Work is performed in Great Britain, United Kingdom. The purchase order supports the NIH Oxford-Cambridge Scholars Program, providing funding for advanced doctoral training. The order has an ultimate completion date of July 31, 2018 and is structured as a firm fixed-price purchase order.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the University of Cambridge valued at $16,000 on July 6, 2018, to support a new member of the NIH Oxford-Cambridge Scholars Program. Performance is to take place in Great Britain, United Kingdom, with an ultimate completion date of July 8, 2019. The order is firm fixed price with no small business set-aside applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to University Of Oxford on January 16, 2020, for one incoming new scholar of the Oxford-Cambridge University Doctoral Partnership Training Program, with a ceiling value of $16,000.00.</p> <p>Performance occurs in Great Britain, United Kingdom. The order carries firm fixed-price pricing and was scheduled for ultimate completion on September 15, 2020.</p>